期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Medical Research Frontier. 2023; 7: (4) ; 5-8 ; DOI: 10.12208/j.imrf.20230035.

Clinical application of Kangfuxin liquid in facial wound repair
康复新液在面部创面修复中的临床应用研究

作者: 陈环 *

天水四零七医院 甘肃天水

*通讯作者: 陈环,单位:天水四零七医院 甘肃天水;

发布时间: 2023-04-05 总浏览量: 248

摘要

目的 分析面部创面修复中采取康复新液治疗的效果。方法 抽取本院在2021年3月-2022年3月期间收治的88例面部创伤患者为研究对象。按照随机数字表法分为两组,其中一组为参考组,本组采取外擦消炎软膏治疗,另一组为实验组,本组在参考组基础上采取康复新液治疗。每组各44例。以治疗有效率、 创面愈合率、疤痕评分及满意度评价两组治疗效果。结果 实验组治疗有效率为95.45%,参考组治疗有效率为77.27%,两组治疗有效率比较,实验组显高(P<0.05)。实验组创面愈合率为93.18%,参考组创面愈合率为72.73%,两组创面愈合率比较,实验组显高(P<0.05)。两组疤痕评分比较,实验组显低(P<0.05)。实验组满意度为97.73%,参考组满意度为75.00%,两组满意度比较,实验组显高(P<0.05)。结论 面部创面修复中采取康复新液治疗的效果确切,能够提升患者的治疗有效率,促进其创面愈合,改善其疤痕情况,为此患者对该治疗效果较为满意。此种方法可在临床上予以推广。

关键词: 康复新液;面部创伤;面部创面修复;治疗有效率;创面愈合率;疤痕评分;满意度

Abstract

Objective To analyze the effectiveness of using Kangfuxin liquid in facial wound repair.
Methods 88 patients with facial trauma admitted to our hospital from March 2021 to March 2022 were selected as the study subjects. Divided into two groups according to the random number table method, one group is the reference group. This group is treated with external anti-inflammatory ointment, and the other group is the experimental group. This group is treated with Kangfuxin liquid on the basis of the reference group. 44 cases in each group. Evaluate the treatment effectiveness of the two groups based on treatment effectiveness, wound healing rate, scar score, and satisfaction.
Results The effective rate of the experimental group was 95.45%, while the effective rate of the reference group was 77.27%. Compared with the two groups, the effective rate of the experimental group was significantly higher (P<0.05). The wound healing rate of the experimental group was 93.18%, while that of the reference group was 72.73%. Compared with the two groups, the wound healing rate of the experimental group was significantly higher (P<0.05). The scar scores of the experimental group were significantly lower compared to the two groups (P<0.05). The satisfaction rate of the experimental group was 97.73%, while the satisfaction rate of the reference group was 75.00%. Compared with the two groups, the satisfaction rate of the experimental group was significantly higher (P<0.05).
Conclusion   The use of Kangfuxin liquid in facial wound repair has a definite effect, which can improve the treatment efficiency of patients, promote wound healing, and improve their scar condition. Therefore, patients are relatively satisfied with the treatment effect. This method can be promoted in clinical practice.

Key words: Kangfu Xin Ye; Facial trauma; Facial wound repair; Treatment effectiveness; Wound healing rate; Scar score; Satisfaction

参考文献 References

[1] 董邢涛, 徐律韵, 许宝华. 整形美容修复技术在急诊面部创伤治疗中的应用[J]. 中国美容医学, 2021, 30(11):4.

[2] 齐珺. 应用皮下蒂皮瓣修复面部创面的临床效果[J]. 医药界, 2021, 021(014):P.1-2.

[3] 邓幼杰,李晨,舒传继.康复新液在颌骨囊肿术后残腔填塞中的应用[J].时珍国医国药,2022,33(09):2207-2208.

[4] 沈喜平.康复新液联合地奥司明片治疗对混合痔术后创面愈合的影响[J].北方药学,2022,19(08):73-75.

[5] 陆世霞.康复新液治疗儿童口腔溃疡有效性及时效性的meta分析[J].北方药学,2022,19(06):76-79.

[6] 徐振华.康复新液联合奥美拉唑对反流性食管炎患者内镜分级及胃泌素、胃动素水平的影响[J].药品评价, 2022, 19(10):626-628.

[7] 曹娟娟,张健民,祝萍等.康复新液对会阴侧切术后产妇切口愈合效果的影响[J].当代医学,2022,28(14):121-123.

[8] Bo L ,  Zhang Y ,  Wu X , et al. Effect and mechanism of Kangfuxin liquid on oral ulcer in patients with chemotherapy treated hematologic malignancies: Network pharmacology study and clinical observations[J]. Informatics in Medicine Unlocked, 2021, 25(4):100693.

[9] 沈德坤.康复新液联合埃索美拉唑在慢性胃炎Hp感染中的应用[J].中国卫生标准管理,2022,13(08):109-111.

[10] 柏林宇,曾惠娜,巫秀美等.康复新液促进创伤修复的网络药理学研究[J].广东化工,2022,49(08):55-58+93.

[11] Wang T ,  Lu H ,  Li F , et al. Effect of Kangfuxin Liquid enema combined with mesalazine on gestational outcomes and quality of life in child-bearing female with active ulcerative colitis: A protocol for randomized, double-blind, controlled trial.[J]. Medicine, 2021, 100(5):23915.

[12] 贾玉洁.口腔种植修复联合康复新液在龈沟液炎性反应治疗中的应用[J].中国民间疗法,2021,29(21):89-91.

[13] 宋名娟,熊清华,汪丹凤.康复新液在面部创面修复中的临床应用研究[J].江西医药, 2021, 56(12): 2165-2166+2176.

引用本文

陈环, 康复新液在面部创面修复中的临床应用研究[J]. 国际医药研究前沿, 2023; 7: (4) : 5-8.